Alessandro Assandri
- Co-authors
- A. BernareggiGiulio GallianiC. GiachettiE. MartinelliG ZanoloS. CanaliL. F. ZerilliP. Anderer
- Topics
- Pharmacogenetics and Drug Metabolism (13 papers)Neuroscience and Neuropharmacology Research (8 papers)Antibiotics Pharmacokinetics and Efficacy (8 papers)
- Cited by
- PharmacologyMolecular Medicine
- Journals
- American Journal of Clinical NutritionAntimicrobial Agents and ChemotherapyJournal of Chromatography A
- Partner nations
- AustriaItalySwitzerland
In The Last Decade
Alessandro Assandri
64 papers receiving 550 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 145
- Pharmacology 142
- Organic Chemistry 83
- Infectious Diseases 69
- Oncology 61
Countries citing papers authored by Alessandro Assandri
This map shows the geographic impact of Alessandro Assandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Assandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Assandri more than expected).
Fields of papers citing papers by Alessandro Assandri
This network shows the impact of papers produced by Alessandro Assandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Assandri. The network helps show where Alessandro Assandri may publish in the future.
Co-authorship network of co-authors of Alessandro Assandri
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Assandri. A scholar is included among the top collaborators of Alessandro Assandri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Assandri. Alessandro Assandri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 3 | |
| 3 | 12 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 11 | |
| 7 | 5 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 14 | |
| 13 | 9 | |
| 14 | 2 | |
| 15 | 9 | |
| 16 | 58 | |
| 17 | 3 | |
| 18 | Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man. | 38 |
| 19 | 6 | |
| 20 | 8 |
About Alessandro Assandri
Alessandro Assandri is a scholar working on Pharmacology, Pharmacology and Biochemistry, having authored 68 papers that have together received 649 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). The work is most often cited by research in Pharmacology (142 citations), Pharmacology (53 citations) and Molecular Medicine (22 citations). Alessandro Assandri has collaborated with scholars based in Austria, Italy and Switzerland. Frequent co-authors include A. Bernareggi, Giulio Galliani, C. Giachetti, E. Martinelli, G Zanolo, S. Canali, L. F. Zerilli, P. Anderer, Pietro Ferrari and Franco Luzzani. Their work appears in journals such as American Journal of Clinical Nutrition, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.